Similarly, in our study, we found that TSG-6 was able to downregulate IFN-α and TNF-α production in CpG-A or R847 stimulated human pDCs, making TSG-6 a potential immunomodulator for autoimmune disorders such as SLE. Here, TNF is linked to autoimmune disease.